| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,927,132 ) |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 2 | NIH | 11/5/2024 | $628,913 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 000 | 5 | NIH | 11/13/2024 | $427,500 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 3 | NIH | 11/13/2024 | $434,294 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AI165580 | Elucidating the Structural Mechanisms of NAIP Receptors in Bacterial Detection and Inflammasome Activation | 001 | 4 | NIH | 11/5/2024 | $465,600 |
| | 2025 | 2025 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R25HG011020 | Epigenomics Workshop for Graduate Students | 000 | 4 | NIH | 11/6/2024 | $51,777 |
| | 2025 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM131754 | Structural mechanism of DNA replication | 000 | 6 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 000 | 1 | NIH | 11/8/2024 | $0 |
| | 2025 | 2023 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K99NS128258 | Structural and Functional Studies on Proton-activated Chloride (PAC) Channel | 000 | 2 | NIH | 11/15/2024 | -$80,952 |
|
| Issue Date FY: 2024 ( Subtotal = $22,595,695 ) (Continued on the next page) |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA284282 | Impact of neurofibromin on ER-alpha and nuclear speck post-transcriptional gene regulation | 000 | 2 | NIH | 8/9/2024 | $47,974 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM138321 | Elucidating structures and molecular mechanisms of Pannexin channels | 000 | 5 | NIH | 6/5/2024 | $475,000 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R50CA243878 | Research Specialist Support- Establishing and Interpreting Abnormal DNA Methylation in Cancer | 000 | 6 | NIH | 7/22/2024 | $166,080 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 000 | 1 | NIH | 4/19/2024 | $46,694 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 001 | 1 | NIH | 4/19/2024 | $0 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F30GM154476 | Upstream Requirements for the Regulation of Mitochondrial Bioenergetics by the Mitochondrial Acyl Carrier Protein | 002 | 1 | NIH | 6/11/2024 | $1,280 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS113894 | Epigenetic contributions to symptom asymmetry in Parkinson's disease | 000 | 5 | NIH | 4/5/2024 | $433,105 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R00CA255928 | Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer | 001 | 4 | NIH | 8/19/2024 | $160,745 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R37CA230748 | High-throughput Epigenomic Mapping of Regulatory Elements in Ovarian Cancer at Basepair Resolution | 001 | 7 | NIH | 7/25/2024 | $353,999 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 001 | 1 | NIH | 7/26/2024 | $5,400 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM147261 | Epigenetic Mechanisms of Retrotransposon Silencing | 000 | 3 | NIH | 7/29/2024 | $475,000 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152184 | Molecular mechanisms of chromatin signaling and epigenetic regulation | 000 | 1 | NIH | 7/19/2024 | $513,000 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 000 | 2 | NIH | 11/3/2023 | $434,294 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA276031 | Mechanisms of cancer mutations | 001 | 2 | NIH | 4/17/2024 | $24,127 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AG084743 | Accelerated DNA Methylation Alterations in Hutchinson-Gilford Progeria Syndrome | 000 | 2 | NIH | 4/25/2024 | $786,197 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS127292 | Molecular mechanisms for sorting lysosomal proteins | 000 | 3 | NIH | 5/17/2024 | $460,750 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM152081 | Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity | 002 | 2 | NIH | 7/26/2024 | $307,200 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01DK139630 | Understanding putative beta-cell subtypes | 000 | 1 | NIH | 6/28/2024 | $698,646 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS121371 | Motor cortical circuitry adaptations in experimental Parkinson's disease | 001 | 4 | NIH | 6/17/2024 | -$427,499 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS121371 | Motor cortical circuitry adaptations in experimental Parkinson's disease | 000 | 4 | NIH | 1/10/2024 | $427,500 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM151245 | Regulation of mitochondrial fatty acid synthesis in the control of mitochondrial metabolism. | 000 | 2 | NIH | 3/22/2024 | $427,500 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 001 | 4 | NIH | 5/3/2024 | $33,250 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM151245 | Regulation of mitochondrial fatty acid synthesis in the control of mitochondrial metabolism. | 001 | 2 | NIH | 7/29/2024 | $47,500 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01NS120489 | LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease | 000 | 4 | NIH | 11/14/2023 | $427,500 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | K22CA272912 | Oncoprotein-regulated lineage plasticity in acute leukemia | 000 | 1 | NIH | 4/18/2024 | $192,240 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01ES036051 | circSATB2, a novel regulator of arsenic-induced carcinogenesis | 000 | 1 | NIH | 1/5/2024 | $604,923 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | T32CA251066 | Cancer Epigenetics Training (CET) Program | 000 | 4 | NIH | 6/17/2024 | $477,477 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35GM142779 | Understanding WNT9A/FZD9 Trafficking and Signaling | 000 | 4 | NIH | 8/28/2024 | $475,000 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21AI173758 | Mechanisms of histone crosstalk with bacterial pathogens | 001 | 2 | NIH | 5/10/2024 | $23,750 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01CA231466 | Molecular mechanisms of protein glycosylation and trafficking | 001 | 7 | NIH | 5/24/2024 | $451,250 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R21AI173758 | Mechanisms of histone crosstalk with bacterial pathogens | 000 | 2 | NIH | 10/30/2023 | $213,750 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01DK132216 | A Trim28-ERV axis drives phenotypic variation in obesity | 000 | 2 | NIH | 7/31/2024 | $575,999 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | U01CA286580 | Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses. | 000 | 1 | NIH | 3/25/2024 | $796,798 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01HG012444 | Master regulators of unexplained variation in disease risk | 000 | 4 | NIH | 9/19/2024 | $1,928,798 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F99CA294248 | Determinants of susceptibility to pediatric acute myeloid leukemia | 000 | 1 | NIH | 8/29/2024 | $49,474 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR084693 | Sexually dimorphic regulation of bone mass by the X-linked histone modifier KDM5C | 001 | 1 | NIH | 8/28/2024 | $6,799 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | F31AG084199 | Identifying Determinants of Tau Pathology Seeding | 001 | 1 | NIH | 6/19/2024 | $0 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R35CA209859 | Establishing and Interpreting Abnormal DNA Methylation in Cancer | 000 | 9 | NIH | 7/3/2024 | $1,065,709 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R03CA290259 | Dissecting the role of germline genetic variation and viral exposures as determinants of hematological disease predisposition | 000 | 1 | NIH | 6/28/2024 | $336,000 |
| | 2024 | 2024 | VAN ANDEL RESEARCH INSTITUTE | 333 BOSTWICK AVE NE | GRAND RAPIDS | MI | 49503-2518 | KENT | USA | R01AR084693 | Sexually dimorphic regulation of bone mass by the X-linked histone modifier KDM5C | 000 | 1 | NIH | 8/15/2024 | $645,930 |
|
